MRK
Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.2% ·
aandelenstroom -0.8% ·
netto nieuwe posities -4.3%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | 0 | 1.60B | $205.64B | +4 | −3 |
| Q1 2026 | 185 | +1 | 1.56B | $186.85B | +3 | −3 |
| Q4 2025 | 183 | 0 | 1.68B | $176.48B | +1 | — |
| Q3 2025 | 27 | 0 | 972.48M | $81.66B | +1 | −2 |
| Q2 2025 | 25 | 0 | 887.01M | $70.29B | +1 | −1 |
| Q1 2025 | 22 | -1 | 386.62M | $34.78B | — | −1 |
| Q4 2024 | 23 | -1 | 374.82M | $37.37B | — | −1 |
| Q3 2024 | 23 | +1 | 256.79M | $29.14B | +1 | — |
| Q2 2024 | 22 | — | 256.16M | $31.70B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 120.91M | — | $12.12B | 0.5% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 80.74M | +6.5% | $8.03B | 1.5% | ▲ Add | 3 | SEC ↗ ×9 |
| 3 | Geode Capital Management ✦ (passief) | 61.18M | +3.4% | $6.07B | 0.5% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passief) | 34.98M | +3.5% | $3.48B | 0.5% | ▲ Add | 3 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 16.11M | +9.9% | $1.60B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 12.51M | -44.3% | $1.24B | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Capital World Investors ✦ | 7.91M | -48.1% | $786.58M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 6.47M | -7.0% | $643.94M | 0.5% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 6.37M | -5.7% | $634.17M | 0.7% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Harris Associates (Oakmark) ✦ | 6.24M | +112.2% | $621.20M | 1.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 5.38M | +77.9% | $533.10M | 0.7% | ▲ Add | 3 | SEC ↗ ×6 |
| 12 | Citadel Advisors ✦ | 5.28M | -25.0% | $525.42M | 0.5% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 3.58M | +99.3% | $356.23M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 1.93M | -0.4% | $191.88M | 0.5% | ▼ Trim | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 1.50M | +0.2% | $148.78M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 1.44M | -7.4% | $143.19M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 1.38M | +27.2% | $137.44M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 425.02K | +37.6% | $42.28M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 19 | Fairfax Financial ✦ | 172.90K | 0.0% | $17.20M | 1.1% | Held | 3 | SEC ↗ |
| 20 | Dodge & Cox ✦ | 157.35K | -0.6% | $15.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 79.16K | -2.2% | $7.88M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 60.40K | -9.6% | $6.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 331 | -90.2% | $32,927 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Soros Fund Management | $34.07M | was 1.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 3,742 houders, 1.88B aandelen, $215.80B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 10.00K aand · $1.35M
Officer · 80.31K aand · $10.72M
Officer · 11.10K aand · $1.46M
Officer · 600 aand · $79,222
Officer · 5.43K aand · $718,261
Officer · 7.41K aand · $973,165
Officer · 20.78K aand · $2.71M
Officer · 805 aand · $105,472
Officer · 4.95K aand · $643,993
Officer · 300 aand · $39,307
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie